NASDAQ$XXII
22nd Century Group Inc. · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
22nd Century Group's Q2 2022 financial results were reported, with revenue increasing due to higher contract manufacturing volumes and the acquisition of GVB Biopharma.
22nd Century Group reported a 73% increase in net sales to $14.5 million for the second quarter of 2022, driven by increased contract manufacturing volumes and the acquisition of GVB Biopharma. The company's VLN pilot in Chicago exceeded expectations, leading to accelerated expansion plans in Colorado. The acquisition of GVB Biopharma is expected to double the company's total revenue and provide consumers with hemp/cannabis products.
- Second quarter net sales increased 73% year-over-year to $14.5 million.
- Successful Chicago pilot of VLN King and VLN Menthol King led to expansion plans in Colorado.
- Acquisition of GVB Biopharma doubled corporate revenue and expanded hemp/cannabis capabilities.
- Balance sheet strengthened with $35 million equity offering to support VLN expansion.
Headline financials
Revenue & EPS history
22nd Century Group · Revenue · Quarterly
$14.5M
Forward guidance
22nd Century Group anticipates decreasing cash requirements, reflecting higher VLN product sales and continued organic growth of GVB's operations, providing adequate liquidity to complete planned strategic initiatives.
Tailwinds
- Successful Chicago pilot exceeding expectations
- Plans for expansion of VLN into the Colorado market
- Advanced discussions with additional channel partners to expand the geographic and regional sales reach of VLN
- Expansion of existing manufacturing operations to increase capacity 25% nearing completion
- Actively pursuing business development through GVB’s existing relationships to further accelerate its growth
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2022
-2.9%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-7.7%
Avg return
30 days after
32%
19 / 59 earnings
Positive
+37.4%
Q4 2020
Best reaction
-25.8%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | -2.2% | -13.2% | — | |
| Q1 2026 | -16.6% | -33.2% | -44.0% | |
| Q3 2025 | -17.0% | -20.0% | -32.3% | |
| Q1 2025 | +1.9% | -18.7% | -59.3% | |
| Q4 2024 | -2.6% | -12.6% | -59.2% | |
| Q3 2024 | -3.0% | -10.7% | -28.2% | |
| Q2 2024 | -14.9% | -21.9% | -62.8% | |
| Q1 2024 | -1.9% | -9.7% | -47.9% | |
| Q4 2023 | -8.7% | -7.7% | -18.1% | |
| Q3 2023 | -15.2% | -19.0% | -52.5% | |
| Q2 2023 | -25.8% | -23.3% | -51.6% | |
| Q1 2023 | -5.0% | -13.8% | -16.1% | |
| Q4 2022 | -0.7% | -4.9% | -17.9% | |
| Q3 2022 | -21.0% | -13.8% | -26.1% | |
| Q2 2022 | -10.7% | -11.2% | -32.7% | |
| Q1 2022 | -8.3% | -20.3% | -3.1% | |
| Q4 2021 | -2.1% | -9.8% | -0.9% | |
| Q3 2021 | -0.7% | +1.7% | -22.1% | |
| Q2 2021 | +18.1% | +26.4% | +12.4% | |
| Q1 2021 | +8.4% | +10.7% | +14.9% | |
| Q4 2020 | +37.4% | +27.0% | +62.6% | |
| Q3 2020 | +13.2% | +12.5% | +129.0% | |
| Q2 2020 | -2.1% | -4.6% | -19.3% | |
| Q1 2020 | -3.6% | -9.9% | -7.7% | |
| Q4 2019 | -5.8% | +2.2% | -7.7% | |
| Q3 2019 | -3.6% | -10.2% | -40.8% | |
| Q2 2019 | +3.1% | +18.9% | +31.4% | |
| Q1 2019 | -11.4% | -18.6% | -18.1% | |
| Q4 2018 | +1.6% | +7.0% | +1.1% | |
| Q3 2018 | +3.1% | +0.8% | +9.8% | |
| Q2 2018 | -1.6% | +2.8% | +2.4% | |
| Q1 2018 | +6.8% | +23.2% | +7.7% | |
| Q4 2017 | +11.3% | +5.8% | -10.1% | |
| Q3 2017 | +0.0% | +5.8% | +28.6% | |
| Q2 2017 | -7.9% | -10.5% | +4.6% | |
| Q1 2017 | +6.9% | +6.9% | +40.5% | |
| Q4 2016 | +0.5% | +3.7% | +44.4% | |
| Q3 2016 | +0.8% | -0.8% | -21.2% | |
| Q2 2016 | +2.2% | +10.9% | +17.4% | |
| Q1 2016 | +2.6% | — | — | |
| Q4 2015 | -4.8% | — | — | |
| Q3 2015 | -9.3% | — | — | |
| Q2 2015 | -7.0% | — | — | |
| Q1 2015 | +21.5% | — | — | |
| Q4 2014 | -16.5% | — | — | |
| Q4 2013 | -16.5% | — | — | |
| Q3 2014 | -9.2% | — | — | |
| Q2 2014 | -1.4% | — | — | |
| Q1 2014 | -2.9% | — | — | |
| Q3 2013 | +4.2% | — | — | |
| Q2 2013 | -18.5% | — | — | |
| Q1 2013 | +0.0% | — | — | |
| Q4 2012 | -9.1% | — | — | |
| Q3 2012 | -20.0% | — | — | |
| Q2 2012 | -7.1% | — | — | |
| Q1 2012 | +1.5% | — | — | |
| Q4 2011 | +1.5% | — | — | |
| Q3 2011 | +0.0% | — | — | |
| Q2 2011 | +0.0% | — | — | |
| Q4 2010 | — | — | — | |
| Q3 2010 | — | — | — | |
| Q2 2010 | — | — | — | |
| Q1 2010 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro